Aktie A065650 HYPER CORPORATION INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Hyper Corporation Inc.

Aktien

A065650

KR7065650004

A065650

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 22.05.2024 		% 5 Tage % 1. Jan.
1.453 KRW -1,36 % Intraday Chart für Hyper Corporation Inc. +0,69 % +47,81 %
28.03. FSN Co., Ltd. (KOSDAQ:A214270), der AI Tech Fund, der Asset Plus Fund und der Open Innovation Fund, die von Benex Investment verwaltet werden, haben den Erwerb einer 22,4%igen Beteiligung an Medifron DBT Co., Ltd. (KOSDAQ:A065650) von Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) und T Scientific Co.,Ltd. (KOSDAQ:A057680) CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.
Medifron DBT to Raise $3.9 Million via Stock Offering
Medifron DBT to Raise $10 Million via Stock Offering
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A065650 Aktie
  4. Nachrichten Hyper Corporation Inc.
  5. Andere Sprachen